PureTech Health PLC

PureTech Health PLC

Health CarePharmaceuticals & Biotechnology
  • Price (GBX)332.00
  • Today's Change-4.00 / -1.19%
  • Shares traded37.19k
  • 1 Year change92.19%
  • Beta0.8861
Data delayed at least 20 minutes, as of Feb 25 2020 12:02 GMT.
More ▼

Key statistics

As of last trade PureTech Health PLC (PRTC:LSE) traded at 332.00, -2.17% below its 52-week high of 339.36, set on Feb 18, 2020.
52-week range
155.50Apr 01 2019339.36Feb 18 2020
Markit short selling activity
Previous close336.00
Average volume107.98k
Shares outstanding285.47m
Free float235.21m
P/E (TTM)--
Market cap962.28m GBP
EPS (TTM)-0.0227
Data delayed at least 20 minutes, as of Feb 25 2020 12:02 GMT.
More ▼

Investors Chronicle View

The last IC recommendation on PureTech Health PLC shares was Buy at 280.00 on 27 Aug 2019Read the full article
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.